Cel-Sci Corp reported a direct purchase of company shares by its chief executive officer, Kersten Geert R., according to a Form 4 filing with the Securities and Exchange Commission. On January 22, 2026, Kersten acquired 38,023 shares of common stock at a price of $5.26 per share. The filing records the total value of the transaction at $200,000. Following the purchase, Kersten's direct holdings in Cel-Sci total 120,815 shares.
In a related disclosure, Cel-Sci's Board of Directors approved revisions to the firm's Shareholder Rights Agreement. The company included the updated agreement as an exhibit to a Form 8-K filed with the SEC. The filing confirms the board action and the inclusion of the revised document but does not provide details about the substance of the changes made to the agreement.
Cel-Sci's common stock continues to trade on the NYSE American exchange. The company characterized the updates as part of ongoing corporate governance activity. The filings supply the factual record of both the insider purchase and the board's approval of amendments to the shareholder rights arrangement; the filings themselves do not elaborate on the intended effects or specific provisions altered by the board.
Below are the key takeaways from the filings and corporate disclosures:
- Insider transaction: CEO Kersten Geert R. purchased 38,023 shares on January 22, 2026 at $5.26 per share, for a total of $200,000.
- Post-transaction ownership: Kersten now directly owns 120,815 shares of Cel-Sci.
- Governance update: The board approved revisions to the Shareholder Rights Agreement, and the revised agreement was attached as an exhibit to the company's Form 8-K; the filing does not describe the revisions.
- Listing status: Cel-Sci's common stock remains listed on the NYSE American exchange.
These disclosures combine a routine insider acquisition with a governance filing. The Form 4 documents the CEO's purchase price and share count, while the Form 8-K records board action and the inclusion of the revised shareholder rights agreement as an exhibit. The filings establish the transactions and corporate actions but leave important details about the content of the governance changes unspecified.